nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—L-Cysteine—GCLC—chronic obstructive pulmonary disease	0.0282	1	CrCbGaD
Penicillamine—Epigastric pain—Aminophylline—chronic obstructive pulmonary disease	0.0247	0.0254	CcSEcCtD
Penicillamine—Trauma—Arformoterol—chronic obstructive pulmonary disease	0.0191	0.0196	CcSEcCtD
Penicillamine—Trauma—Formoterol—chronic obstructive pulmonary disease	0.0191	0.0196	CcSEcCtD
Penicillamine—Trauma—Montelukast—chronic obstructive pulmonary disease	0.0187	0.0192	CcSEcCtD
Penicillamine—Peptic ulcer—Aminophylline—chronic obstructive pulmonary disease	0.0179	0.0184	CcSEcCtD
Penicillamine—Epigastric pain—Salbutamol—chronic obstructive pulmonary disease	0.0177	0.0183	CcSEcCtD
Penicillamine—Appetite absent—Salbutamol—chronic obstructive pulmonary disease	0.0172	0.0177	CcSEcCtD
Penicillamine—Atrophy—Prednisolone—chronic obstructive pulmonary disease	0.0151	0.0155	CcSEcCtD
Penicillamine—Extravasation—Aminophylline—chronic obstructive pulmonary disease	0.0137	0.0141	CcSEcCtD
Penicillamine—Glossitis—Tiotropium—chronic obstructive pulmonary disease	0.0122	0.0126	CcSEcCtD
Penicillamine—Coagulopathy—Salbutamol—chronic obstructive pulmonary disease	0.011	0.0113	CcSEcCtD
Penicillamine—Atrophy—Prednisone—chronic obstructive pulmonary disease	0.011	0.0113	CcSEcCtD
Penicillamine—Trauma—Prednisolone—chronic obstructive pulmonary disease	0.0103	0.0106	CcSEcCtD
Penicillamine—Mouth ulceration—Tiotropium—chronic obstructive pulmonary disease	0.0102	0.0105	CcSEcCtD
Penicillamine—Leukocytosis—Formoterol—chronic obstructive pulmonary disease	0.00966	0.00994	CcSEcCtD
Penicillamine—Leukocytosis—Arformoterol—chronic obstructive pulmonary disease	0.00966	0.00994	CcSEcCtD
Penicillamine—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00947	0.00974	CcSEcCtD
Penicillamine—Glossitis—Salbutamol—chronic obstructive pulmonary disease	0.00931	0.00958	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00918	0.00945	CcSEcCtD
Penicillamine—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.00912	0.00938	CcSEcCtD
Penicillamine—Neuropathy—Montelukast—chronic obstructive pulmonary disease	0.00835	0.00859	CcSEcCtD
Penicillamine—Optic neuritis—Prednisolone—chronic obstructive pulmonary disease	0.008	0.00823	CcSEcCtD
Penicillamine—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00791	0.00814	CcSEcCtD
Penicillamine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00787	0.0081	CcSEcCtD
Penicillamine—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00766	0.00788	CcSEcCtD
Penicillamine—Trauma—Prednisone—chronic obstructive pulmonary disease	0.00751	0.00773	CcSEcCtD
Penicillamine—Peptic ulcer—Prednisolone—chronic obstructive pulmonary disease	0.00736	0.00757	CcSEcCtD
Penicillamine—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.0073	0.00751	CcSEcCtD
Penicillamine—Injury—Formoterol—chronic obstructive pulmonary disease	0.00717	0.00738	CcSEcCtD
Penicillamine—Injury—Arformoterol—chronic obstructive pulmonary disease	0.00717	0.00738	CcSEcCtD
Penicillamine—Injury—Montelukast—chronic obstructive pulmonary disease	0.00703	0.00723	CcSEcCtD
Penicillamine—Injury—Salbutamol—chronic obstructive pulmonary disease	0.00677	0.00697	CcSEcCtD
Penicillamine—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00676	0.00695	CcSEcCtD
Penicillamine—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00676	0.00695	CcSEcCtD
Penicillamine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00664	0.00683	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00661	0.00681	CcSEcCtD
Penicillamine—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00638	0.00656	CcSEcCtD
Penicillamine—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00637	0.00655	CcSEcCtD
Penicillamine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.0062	0.00638	CcSEcCtD
Penicillamine—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00619	0.00637	CcSEcCtD
Penicillamine—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00614	0.00631	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00582	0.00599	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00582	0.00598	CcSEcCtD
Penicillamine—Optic neuritis—Prednisone—chronic obstructive pulmonary disease	0.00581	0.00598	CcSEcCtD
Penicillamine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.0057	0.00586	CcSEcCtD
Penicillamine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.0057	0.00586	CcSEcCtD
Penicillamine—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00569	0.00585	CcSEcCtD
Penicillamine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00558	0.00574	CcSEcCtD
Penicillamine—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00558	0.00574	CcSEcCtD
Penicillamine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00555	0.00571	CcSEcCtD
Penicillamine—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00554	0.0057	CcSEcCtD
Penicillamine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00553	0.00569	CcSEcCtD
Penicillamine—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00547	0.00563	CcSEcCtD
Penicillamine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00538	0.00554	CcSEcCtD
Penicillamine—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.00535	0.0055	CcSEcCtD
Penicillamine—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.0053	0.00545	CcSEcCtD
Penicillamine—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00513	0.00528	CcSEcCtD
Penicillamine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00507	0.00522	CcSEcCtD
Penicillamine—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00504	0.00519	CcSEcCtD
Penicillamine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00495	0.0051	CcSEcCtD
Penicillamine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00488	0.00502	CcSEcCtD
Penicillamine—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00484	0.00498	CcSEcCtD
Penicillamine—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00484	0.00498	CcSEcCtD
Penicillamine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00479	0.00493	CcSEcCtD
Penicillamine—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00471	0.00484	CcSEcCtD
Penicillamine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0047	0.00484	CcSEcCtD
Penicillamine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.0047	0.00484	CcSEcCtD
Penicillamine—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00468	0.00481	CcSEcCtD
Penicillamine—Neuropathy—Prednisolone—chronic obstructive pulmonary disease	0.00462	0.00475	CcSEcCtD
Penicillamine—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00457	0.00471	CcSEcCtD
Penicillamine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.0045	0.00464	CcSEcCtD
Penicillamine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.0045	0.00464	CcSEcCtD
Penicillamine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00447	0.0046	CcSEcCtD
Penicillamine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00447	0.0046	CcSEcCtD
Penicillamine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00443	0.00455	CcSEcCtD
Penicillamine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00441	0.00454	CcSEcCtD
Penicillamine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00438	0.00451	CcSEcCtD
Penicillamine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00437	0.0045	CcSEcCtD
Penicillamine—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00433	0.00445	CcSEcCtD
Penicillamine—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00431	0.00443	CcSEcCtD
Penicillamine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00425	0.00438	CcSEcCtD
Penicillamine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00422	0.00434	CcSEcCtD
Penicillamine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00419	0.00431	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00416	0.00428	CcSEcCtD
Penicillamine—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00412	0.00424	CcSEcCtD
Penicillamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00406	0.00418	CcSEcCtD
Penicillamine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00406	0.00418	CcSEcCtD
Penicillamine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00403	0.00414	CcSEcCtD
Penicillamine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00402	0.00414	CcSEcCtD
Penicillamine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00402	0.00413	CcSEcCtD
Penicillamine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.004	0.00411	CcSEcCtD
Penicillamine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.004	0.00411	CcSEcCtD
Penicillamine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00391	0.00403	CcSEcCtD
Penicillamine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00391	0.00402	CcSEcCtD
Penicillamine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.0039	0.00401	CcSEcCtD
Penicillamine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00389	0.004	CcSEcCtD
Penicillamine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00389	0.004	CcSEcCtD
Penicillamine—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00388	0.004	CcSEcCtD
Penicillamine—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.0038	0.00391	CcSEcCtD
Penicillamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00379	0.0039	CcSEcCtD
Penicillamine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00377	0.00388	CcSEcCtD
Penicillamine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0037	0.00381	CcSEcCtD
Penicillamine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00378	CcSEcCtD
Penicillamine—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00366	0.00377	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00366	0.00376	CcSEcCtD
Penicillamine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00365	0.00375	CcSEcCtD
Penicillamine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00365	0.00375	CcSEcCtD
Penicillamine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00357	0.00368	CcSEcCtD
Penicillamine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00345	0.00355	CcSEcCtD
Penicillamine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00338	0.00348	CcSEcCtD
Penicillamine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00338	0.00348	CcSEcCtD
Penicillamine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00338	0.00348	CcSEcCtD
Penicillamine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00337	0.00347	CcSEcCtD
Penicillamine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00337	0.00347	CcSEcCtD
Penicillamine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00337	0.00346	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00336	0.00345	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00336	0.00345	CcSEcCtD
Penicillamine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.00336	0.00345	CcSEcCtD
Penicillamine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00331	0.00341	CcSEcCtD
Penicillamine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0033	0.0034	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00329	0.00338	CcSEcCtD
Penicillamine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00328	CcSEcCtD
Penicillamine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00319	0.00328	CcSEcCtD
Penicillamine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00318	0.00327	CcSEcCtD
Penicillamine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00315	0.00324	CcSEcCtD
Penicillamine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00315	0.00324	CcSEcCtD
Penicillamine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00315	0.00324	CcSEcCtD
Penicillamine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00314	0.00323	CcSEcCtD
Penicillamine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00311	0.0032	CcSEcCtD
Penicillamine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00308	0.00317	CcSEcCtD
Penicillamine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00303	0.00311	CcSEcCtD
Penicillamine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.003	0.00308	CcSEcCtD
Penicillamine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00297	0.00306	CcSEcCtD
Penicillamine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00296	0.00304	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00295	0.00304	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00295	0.00304	CcSEcCtD
Penicillamine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.003	CcSEcCtD
Penicillamine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00291	0.003	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00289	0.00298	CcSEcCtD
Penicillamine—Injury—Prednisone—chronic obstructive pulmonary disease	0.00282	0.0029	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00287	CcSEcCtD
Penicillamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00271	0.00279	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.0027	0.00278	CcSEcCtD
Penicillamine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00268	0.00276	CcSEcCtD
Penicillamine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00268	0.00276	CcSEcCtD
Penicillamine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.00274	CcSEcCtD
Penicillamine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00257	0.00265	CcSEcCtD
Penicillamine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00257	0.00265	CcSEcCtD
Penicillamine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00264	CcSEcCtD
Penicillamine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00264	CcSEcCtD
Penicillamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00255	0.00263	CcSEcCtD
Penicillamine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00253	0.00261	CcSEcCtD
Penicillamine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00253	0.0026	CcSEcCtD
Penicillamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00253	0.0026	CcSEcCtD
Penicillamine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00252	0.00259	CcSEcCtD
Penicillamine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00251	0.00258	CcSEcCtD
Penicillamine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00248	0.00255	CcSEcCtD
Penicillamine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00247	0.00254	CcSEcCtD
Penicillamine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00243	0.0025	CcSEcCtD
Penicillamine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00249	CcSEcCtD
Penicillamine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00239	0.00246	CcSEcCtD
Penicillamine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00239	0.00246	CcSEcCtD
Penicillamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00239	0.00245	CcSEcCtD
Penicillamine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00234	0.00241	CcSEcCtD
Penicillamine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00229	0.00235	CcSEcCtD
Penicillamine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00232	CcSEcCtD
Penicillamine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00228	CcSEcCtD
Penicillamine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00228	CcSEcCtD
Penicillamine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.0022	0.00226	CcSEcCtD
Penicillamine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00223	CcSEcCtD
Penicillamine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00215	CcSEcCtD
Penicillamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00212	CcSEcCtD
Penicillamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00212	CcSEcCtD
Penicillamine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00204	0.0021	CcSEcCtD
Penicillamine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.0021	CcSEcCtD
Penicillamine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00204	0.0021	CcSEcCtD
Penicillamine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.0021	CcSEcCtD
Penicillamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00202	0.00208	CcSEcCtD
Penicillamine—Rash—Montelukast—chronic obstructive pulmonary disease	0.002	0.00206	CcSEcCtD
Penicillamine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.002	0.00206	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00196	0.00202	CcSEcCtD
Penicillamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.002	CcSEcCtD
Penicillamine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00199	CcSEcCtD
Penicillamine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00198	CcSEcCtD
Penicillamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00192	0.00198	CcSEcCtD
Penicillamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00192	0.00198	CcSEcCtD
Penicillamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Penicillamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00187	CcSEcCtD
Penicillamine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.0018	0.00186	CcSEcCtD
Penicillamine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00185	CcSEcCtD
Penicillamine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00168	CcSEcCtD
Penicillamine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00159	0.00163	CcSEcCtD
Penicillamine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00162	CcSEcCtD
Penicillamine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00149	CcSEcCtD
Penicillamine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00148	CcSEcCtD
Penicillamine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00143	CcSEcCtD
Penicillamine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00137	CcSEcCtD
Penicillamine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00136	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00136	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00133	CcSEcCtD
Penicillamine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00127	CcSEcCtD
Penicillamine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00125	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00116	0.0012	CcSEcCtD
Penicillamine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00114	CcSEcCtD
Penicillamine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00114	CcSEcCtD
Penicillamine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00114	CcSEcCtD
Penicillamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00107	CcSEcCtD
Penicillamine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00104	CcSEcCtD
Penicillamine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00104	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00094	0.000967	CcSEcCtD
Penicillamine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000873	0.000898	CcSEcCtD
Penicillamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000811	0.000834	CcSEcCtD
Penicillamine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000804	0.000827	CcSEcCtD
Penicillamine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000803	0.000827	CcSEcCtD
Penicillamine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000757	0.000779	CcSEcCtD
